Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth

Leukemia

Volumn 13, Issue 6, 1999, Pages 855-861

  Roginskaya, V ^a   Zuo, S ^a   Caudell, E ^a   Nambudiri, G ^b   Kraker, A J ^c   Corey, S J ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

Chemotherapy; Leukemia; Lyn; Tyrosine kinase

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PD 166285; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BLAST CELL; CELL GROWTH; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0032969381     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401429     Document Type: Article

References (31)

1. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei E 3rd. Intensive post-remission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. New Engl J Med 1994; 331: 896-903.
2. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta 1996; 1287: 121-149.
3. Torigoe T, O'Connor R, Fagard R, Fischer S, Santoli D, Reed JC. Regulation of SRC-family protein tyrosine kinases by interleukins, IL-2, and IL-3. Leukemia 1992; 3: 94S-97S.
4. Corey S, Eguinoa A, Puyana-Theall K, Bolen JB, Cantley L, Mollinedo F, Jackson TR, Hawkins PT, Stephens LR. Granulocytemacrophage colony-stimulating factor activates Ptdlns 3OH-kinase via src-related tyrosine kinase(s) in human myeloid-derived cells. EMBO J 1993; 12: 2681-2690.
5. Wei S, Liu JH, Epling-Burnette PK, Gamero AM, Ussery D, Pearson EW, Elkabani ME, Diaz JI, Djeu JY. Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J Immunol 1996; 157: 5155-5162.
6. Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ. G-CSF receptor signalling involves the formation of a three-component complex with lyn and syk protein-tyrosine kinases. Proc Natl Acad Sci USA 1994; 91: 4683-4687.
7. Panek RL, Lu GH, Klutchko SR, Batley BL, Dahring TK, Hamby JM, Hallak H, Doherty AM, Keiser JA. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. J Pharm Exp Ther 1997; 283: 1433-1444.
8. Burkhardt AL, Brunswick M, Bolen JB, Mond JJ. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci USA 1991; 88: 7410-7414.
9. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol 1992; 66: 5161-5167.
10. Bell GM, Bolen JB, Imboden JB. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol Cell Biol 1992; 12: 5548-5554.
11. Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, Burkhardt AL, Tsukada S, Witte ON, Bolen JB. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci USA 1994; 91: 9524-9528.
12. Gauen LK, Zhu Y, Letourneur F, Hu Q, Bolen JB, Matis LA, Klausner RD, Shaw AS. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol 1994; 14: 3729-3741.
13. Katagiri K, Yokoyama KK, Yamamoto T, Omura S, Irie S, Katagiri T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem 1996; 271: 11557-11566.
14. Scheuermann RH, Racila E, Tucker T, Yefenof E, Street NE, Vitetta ES, Picker LJ, Uhr JW. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc Natl Acad Sci USA 1994; 91: 4048-4052.
15. Corey SJ, Dombrosky-Ferlan PM, Zuo S, Krohn E, Donnenberg AD, Zorich P, Romero G, Takata M, Kurosaki T. Requirement of src kinase lyn for induction of DNA synthesis by granulocyte colony-stimulating factor. J Biol Chem 1998; 273: 3230-3235.
16. Vellenga E, Young DC, Wagner K, Wiper D, Ostapovicz D, Griffin JD. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood 1987; 69: 1771-1776.
17. Young DC, Griffin JD. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178-1181.
18. Griffin JD, Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood 1986; 68: 1185-1195.
19. Young DC, Wagner K, Griffin JD. Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia. J Clin Invest 1987; 79: 100-106.
20. Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Tuow IP. Mutations in the gene for the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New Engl J Med 1995; 333: 487-493.
21. Touw IP, Schelen A, Brynes RK, Tidow W, Welte K, Lowenberg B, Dong F. Point mutations in the G-CSFR gene in severe congenital neutropenia terminating in acute myeloid leukemia. Blood 1994; 84: 375.
22. Anderson SM, Jorgensen B. Activation of src-related tyrosine kinases by IL-3. J Immunol 1995; 155: 1660-1670.
23. Torigoe T, O'Connor R, Santoli D, Reed JC. Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood 1992; 80: 617-624.
24. Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Cancer Res 1996; 56: 3589-3596.
25. Uckun FM, Evans WE, Forsyth CJ, Waddick KG, Ahlgren LT, Chelstrom LM, Burkhardt A, Bolen J, Myers DE. Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 1995; 267: 886-889.
26. Finlay GJ, Holdaway KM, Baguley BC. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation. Oncol Res 1995; 6: 33-37.
27. Dombrosky-Ferlan PM, Corey SJ. Yeast two-hybrid in vivo association of src kinase Lyn with the proto-oncogene product Cbl but not with the p85 subunit of P1 3-kinase. Oncogene 1997; 14: 2019-2024.
28. Uckun FM, Tuel-Ahlgren L, Waddick KG, Jun X, Jin J, Myers DE, Rowley RB, Burkhardt AL, Bolen JB. Physical and functional interactions between Lyn and p34cdc2 kinases in irradiated human B-cell precursors. J Biol Chem 1996; 271: 6389-6397.
29. Kharbanda S, Saleem A, Yuan ZM, Kraeft S, Weichselbaum R, Chen LB, Kufe D. Nuclear signaling induced by ionizing radiation involves colocalization of the activated p56/p53lyn tyrosine kinase with p34cdc2. Cancer Res 1996; 56: 3617-3621.
30. Pathan NI, Geahlen RL, Harrison ML. The protein-tyrosine kinase Lck associates with and is phosphorylated by Cdc2. J Biol Chem 1996; 271: 27517-27523.
31. Corey SJ, Anderson SM. Src-related protein tyrosine kinases in hematopoiesis. Blood 1999; 93: 1-14.